Cementos Pacasmayo S.A.A.
NYSE:CPACConstruction Materials
+$0.08 today
- Market cap
- $1.10B
- Beta
- 0.13
- P/E (TTM)
- 19.0
- EPS (TTM)
- $2.13
- Dividend yield
- 5.09%
Volume 0.47M
Average 0.03M
CPAC Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Cementos Pacasmayo S.A.A.NYSE: CPAC
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was PEN 0, compared with PEN 0 a year earlier. Trailing-twelve-month research & development was PEN 0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near PEN 0 or moves back toward the trailing-twelve-month quarterly average of PEN 0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
PEN · from the income statement
- Latest · FY2025
- 0 PEN
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How CPAC compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for CPAC, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $11.89M USD | -22.2% | -3.5% | 4891.2% | |
| LTM Mar 2026 | PEN 0 PEN | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
LARLithium Argentina AG | LTM Mar 2026 | $0 USD | — | — | — |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Feb 2026 | $0 USD | — | — | — | |
| LTM Mar 2026 | $0 USD | — | — | — | |
| Peer median (excluding CPAC) | — | -61.1% | -3.5% | 0.0% | |
Competitors are the stored peer set for CPAC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.94B | 2.12B | 1.95B | 1.98B | 2.12B |
| Cost of Revenue | 1.38B | 1.46B | 1.26B | 1.25B | 1.31B |
| Gross Profit | 559.43M | 652.03M | 689.45M | 728.53M | 806.87M |
| Gross Margin | 28.9% | 30.8% | 35.4% | 36.8% | 38.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 224.89M | 268.51M | 281.83M | 308.98M | 357.69M |
| Operating Expenses | 241.18M | 296.71M | 303.95M | 337.49M | 382.14M |
| Depreciation & Amortization | 135.57M | 138.54M | 144.2M | 158.25M | 159.48M |
| EBITDA | 431.45M | 477.71M | 490.83M | 553.41M | 518.83M |
| EBITDA Margin | 22.3% | 22.6% | 25.2% | 28.0% | 24.5% |
| Operating Income | 318.25M | 355.32M | 385.5M | 391.03M | 424.73M |
| Operating Margin | 16.4% | 16.8% | 19.8% | 19.8% | 20.1% |
| Interest Income | 2.89M | 3.31M | 3.96M | 6.3M | 10.64M |
| Interest Expense | 88.97M | 95.11M | 100.76M | 98.97M | 86.74M |
| Other Income / Expenses | (94.14M) | (92.9M) | (139.79M) | (94.85M) | (156.75M) |
| Income Before Tax | 224.11M | 262.42M | 245.71M | 296.19M | 267.98M |
| Pre-Tax Margin | 11.6% | 12.4% | 12.6% | 15.0% | 12.7% |
| Income Tax Expense | 70.94M | 85.59M | 76.81M | 97.31M | 113.77M |
| Net Income | 153.17M | 176.83M | 168.9M | 198.88M | 154.21M |
| Net Margin | 7.9% | 8.4% | 8.7% | 10.1% | 7.3% |
| EPS (Basic) | 1.80 | 2.05 | 1.95 | 2.30 | 1.70 |
| EPS (Diluted) | 1.80 | 2.05 | 1.95 | 2.30 | 1.70 |
| Weighted Avg Shares | 85.62M | 85.62M | 85.62M | 85.62M | 85.62M |
| Weighted Avg Shares (Diluted) | 85.62M | 85.62M | 85.62M | 85.62M | 85.62M |
Cementos Pacasmayo S.A.A.
NYSE:CPAC
Intrinsic Alpha fair value
Locked
Current Price
$12.83
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.